Loukia G. Karacosta, Ph.D.
Affiliations: | Pharmacology & Toxicology | State University of New York, Buffalo, Buffalo, NY, United States |
Area:
Protein KinasesGoogle:
"Loukia Karacosta"Mean distance: 18.57 (cluster 11) | S | N | B | C | P |
Parents
Sign in to add mentor| Arthur M. Edelman | grad student | 2013 | SUNY Buffalo | |
| (The role of CaMKK2 in prostate cancer progression.) | ||||
| Sylvia K. Plevritis | post-doc | (MathTree) | ||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Karacosta LG, Pancirer D, Preiss JS, et al. (2023) Phenotyping EMT and MET cellular states in lung cancer patient liquid biopsies at a personalized level using mass cytometry. Scientific Reports. 13: 21781 |
| Bouchard G, Garcia-Marques FJ, Karacosta LG, et al. (2021) Multi-omics analysis of spatially distinct stromal cells reveals tumor-induced O-glycosylation of the CDK4-pRB axis in fibroblasts at the invasive tumor edge. Cancer Research |
| Karacosta LG, Anchang B, Ignatiadis N, et al. (2019) Mapping lung cancer epithelial-mesenchymal transition states and trajectories with single-cell resolution. Nature Communications. 10: 5587 |
| Karacosta L, Anchang B, Ignatiadis N, et al. (2019) OA08.03 A Single-Cell Resolution Map of EMT and Drug Resistance States for Evaluating NSCLC Clinical Specimens Journal of Thoracic Oncology. 14: S226-S227 |
| Anchang B, Davis KL, Fienberg HG, et al. (2018) DRUG-NEM: Optimizing drug combinations using single-cell perturbation response to account for intratumoral heterogeneity. Proceedings of the National Academy of Sciences of the United States of America |
| Karacosta LG, Fisk JC, Jessee J, et al. (2018) Preclinical Analysis of JAA-F11, a Specific Anti-Thomsen-Friedenreich Antibody via Immunohistochemistry and In Vivo Imaging. Translational Oncology. 11: 450-466 |
| Karacosta LG, Anchang B, Kimmey S, et al. (2018) Abstract 4997: Identifying dynamic EMT states and constructing a proteomic EMT landscape of lung cancer using single cell multidimensional analysis Tumor Biology |
| Anchang B, Davis K, Fienberg H, et al. (2018) Abstract 2275: Individualized drug combination based on single-cell drug perturbations Cancer Research. 78: 2275-2275 |
| Toumazis I, Kurt M, Toumazi A, et al. (2017) Comparative Effectiveness of Up To Three Lines of Chemotherapy Treatment Plans for Metastatic Colorectal Cancer. Mdm Policy & Practice. 2: 2381468317729650 |
| Tati S, Fisk JC, Abdullah J, et al. (2017) Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and InVitro Efficacy Analysis. Neoplasia (New York, N.Y.). 19: 716-733 |